TY - JOUR
T1 - The longitudinal evaluation of familial frontotemporal dementia subjects protocol
T2 - Framework and methodology
AU - on Behalf of the LEFFTDS Consortium
AU - Boeve, Bradley
AU - Bove, Jessica
AU - Brannelly, Patrick
AU - Brushaber, Danielle
AU - Coppola, Giovanni
AU - Dever, Rielly
AU - Dheel, Christina
AU - Dickerson, Bradford
AU - Dickinson, Susan
AU - Faber, Kelley
AU - Fields, Julie
AU - Fong, Jamie
AU - Foroud, Tatiana
AU - Forsberg, Leah
AU - Gavrilova, Ralitza
AU - Gearhart, Debra
AU - Ghoshal, Nupur
AU - Goldman, Jennifer
AU - Graff-Radford, Jonathan
AU - Graff-Radford, Neill
AU - Grossman, Murray
AU - Haley, Dana
AU - Heuer, Hilary
AU - Hsiung, Ging Yuek Robin
AU - Huey, Edward
AU - Irwin, David
AU - Jones, David
AU - Jones, Lynne
AU - Kantarci, Kejal
AU - Karydas, Anna
AU - Knopman, David
AU - Kornak, John
AU - Kraft, Ruth
AU - Kramer, Joel
AU - Kremers, Walter
AU - Kukull, Walter
AU - Lapid, Maria
AU - Lucente, Diane
AU - Mackenzie, Ian
AU - Manoochehri, Masood
AU - McGinnis, Scott
AU - Miller, Bruce
AU - Pearlman, Rodney
AU - Petrucelli, Len
AU - Potter, Madeline
AU - Rademakers, Rosa
AU - Ramos, Eliana Marisa
AU - Rankin, Kate
AU - Rascovsky, Katya
AU - Sengdy, Pheth
N1 - Funding Information:
Funding: This work is supported by the National Institutes of Health [grants U01 AG045390 , U54 NS092089 , U24 AG021886 , and U01 AG016976 ].
Publisher Copyright:
© 2019 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Introduction: It is important to establish the natural history of familial frontotemporal lobar degeneration (f-FTLD) and provide clinical and biomarker data for planning these studies, particularly in the asymptomatic phase. Methods: The Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects protocol was designed to enroll and follow at least 300 subjects for more than at least three annual visits who are members of kindreds with a mutation in one of the three most common f-FTLD genes—microtubule-associated protein tau, progranulin, or chromosome 9 open reading frame 72. Results: We present the theoretical considerations of f-FTLD and the aims/objectives of this protocol. We also describe the design and methodology for evaluating and rating subjects, in which detailed clinical and neuropsychological assessments are performed, biofluid samples are collected, and magnetic resonance imaging scans are performed using a standard protocol. Discussion: These data and samples, which are available to interested investigators worldwide, will facilitate planning for upcoming disease-modifying therapeutic trials in f-FTLD.
AB - Introduction: It is important to establish the natural history of familial frontotemporal lobar degeneration (f-FTLD) and provide clinical and biomarker data for planning these studies, particularly in the asymptomatic phase. Methods: The Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects protocol was designed to enroll and follow at least 300 subjects for more than at least three annual visits who are members of kindreds with a mutation in one of the three most common f-FTLD genes—microtubule-associated protein tau, progranulin, or chromosome 9 open reading frame 72. Results: We present the theoretical considerations of f-FTLD and the aims/objectives of this protocol. We also describe the design and methodology for evaluating and rating subjects, in which detailed clinical and neuropsychological assessments are performed, biofluid samples are collected, and magnetic resonance imaging scans are performed using a standard protocol. Discussion: These data and samples, which are available to interested investigators worldwide, will facilitate planning for upcoming disease-modifying therapeutic trials in f-FTLD.
KW - C9orf72
KW - Frontotemporal dementia
KW - GRN
KW - Genetics
KW - MAPT
KW - TDP-43
KW - Tau
UR - http://www.scopus.com/inward/record.url?scp=85073823606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073823606&partnerID=8YFLogxK
U2 - 10.1016/j.jalz.2019.06.4947
DO - 10.1016/j.jalz.2019.06.4947
M3 - Article
C2 - 31636026
AN - SCOPUS:85073823606
SN - 1552-5260
VL - 16
SP - 22
EP - 36
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 1
ER -